Category 1

Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis:

Christos Chinopoulos and Thomas N. Seyfried
Category 1
09/11/2025

Topics

Glioblastoma multiforme (GBM) carries the highest mortalityrate among primary brain tumors and remains largelyunmanageable. Life expectancy following diagnosis isonly about 12 to 14 months. This has changed little fordecades despite continuing research (Fisher and Buffler,2005; Krex et al., 2007; Stupp et al., 2009; Lawrence et al.,2011; Ahmadloo et al., 2013; Alexander and Cloughesy,2017). Indeed, a recent reevaluation found that overallsurvival for GBM is woefully similar to that reported byCushing almost a century ago (Fatehi et al., 2018). Adefining characteristic of GBM is the secondary structuresof Scherer, which include diffuse parenchymal growthinvasion over the subpial surface, along white mattertracks, and through the Virchow–Robin spaces (Scherer,1940; Laws et al., 1993; Kleihues and Ohgaki, 1999;

Read More

Other Publications of Interest

Category 3

Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma:

Temozolomide (TMZ) is part of the standard of care for treatingIntroduction: Temozolomide (TMZ) is part of the standard of care

Category 4

Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Introduction No major advances have been made in improving overall survival for glioblastoma (GBM) in almost 100 years. The currentNo

Category 4

Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma:

Introduction Glioblastoma (GBM) is an aggressive primary human brain tumour that has resisted effectiveGlioblastoma (GBM) is an aggressive primary human